-
201
Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment
Published 2024-10-01“…Abstract INTRODUCTION Previous studies have examined the predictive accuracy of plasma amyloid beta (Aβ) biomarkers in clinical cohorts. However, their accuracy for predicting amyloid‐positive patients in community‐based cohorts is unclear. …”
Get full text
Article -
202
Nicotinamide Ameliorates Amyloid Beta-Induced Oxidative Stress-Mediated Neuroinflammation and Neurodegeneration in Adult Mouse Brain
Published 2021-04-01“…Alzheimer’s disease (AD) is the most predominant age-related neurodegenerative disease, pathologically characterized by the accumulation of aggregates of amyloid beta Aβ<sub>1–42</sub> and tau hyperphosphorylation in the brain. …”
Get full text
Article -
203
Curcumin Derivative GT863 Inhibits Amyloid-Beta Production via Inhibition of Protein N-Glycosylation
Published 2020-02-01Get full text
Article -
204
The Impact of Amyloid-Beta Positivity with 18F-Florbetaben PET on Neuropsychological Aspects in Parkinson’s Disease Dementia
Published 2020-09-01“…Four patients (17.4%) showed significant amyloid burden. Patients with amyloid-beta showed poorer performance in executive function and more severe neuropsychiatric symptoms than those without amyloid-beta. …”
Get full text
Article -
205
Higher Level of Mismatch in 4 Carriers for Amyloid-Beta Peptide Alzheimer’s Disease Biomarkers in Cerebrospinal Fluid
Published 2019-05-01“…Even though there is a causal correlation between apolipoprotein E ( APOE ) genotype and amyloid-beta (Aβ), the determination of APOE is currently not supported by national or international guidelines. …”
Get full text
Article -
206
Effect of hormone replacement therapy on amyloid beta (Aβ) plaque density in the rhesus macaque amygdala
Published 2024-01-01“…BackgroundAmyloid beta (Aβ) plaque density was examined in the amygdala of rhesus macaques, to elucidate the influence of age, diet and hormonal environment.MethodsLuminex technology was used to measure cerebrospinal fluid (CSF) concentrations of Aβ40 and Aβ42 across three decades, while immunohistochemistry was used to examine Aβ plaque density in the amygdala.ResultsAβ40 was found to be the predominant isoform of Aβ in the CSF, but neither Aβ40 or Aβ42 concentrations showed an age-related change, and the ratio of Aβ42 to Aβ40 showed only a marginal increase. …”
Get full text
Article -
207
Plasma amyloid-beta levels correlated with impaired hepatic functions: An adjuvant biomarker for the diagnosis of biliary atresia
Published 2022-09-01Subjects: Get full text
Article -
208
-
209
Do radiomics or diffusion-tensor images provide additional information to predict brain amyloid-beta positivity?
Published 2023-06-01“…The study population included 72 patients with MCI in the amyloid-beta-negative group and 114 patients with MCI in the amyloid-beta-positive group. …”
Get full text
Article -
210
Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer’s Disease
Published 2019-12-01“…Keywords: Alzheimer, synapse, amyloid beta, tau, array tomography, microglia…”
Get full text
Article -
211
Neurotoxicity of Amyloid Beta and its Association with other Biomarkers in Pathogenesis of Alzheimer’s Disease: A Narrative Review
Published 2024-10-01“…Amyloid beta (Aβ) deposition in the brain is regarded as an early toxic effect in the aetiopathogenesis of Alzheimer’s Disease (AD). …”
Get full text
Article -
212
Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities
Published 2024-05-01“…Abstract Therapeutic antibodies have been developed to target amyloid-beta (Aβ), and some of these slow the progression of Alzheimer’s disease (AD). …”
Get full text
Article -
213
Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta
Published 2016-03-01“…Cholinesterases and amyloid beta are one of the major biological targets in the search for a new and efficacious treatment of Alzheimer’s disease. …”
Get full text
Article -
214
Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity.
Published 2012-01-01“…Aggregates of amyloid-beta (Aβ) peptides are thought to be involved in the development of Alzheimer's disease because they can change synaptic plasticity and induce neuronal cell death by inflammation, oxidative damage, and transmembrane pore formation. …”
Get full text
Article -
215
-
216
Aducanumab and lecanemab – two novel antibodies against pathologic species of amyloid beta in the treatment of Alzheimer’s disease
Published 2023-05-01Subjects: Get full text
Article -
217
Ginsenoside F1 Protects the Brain against Amyloid Beta-Induced Toxicity by Regulating IDE and NEP
Published 2022-01-01“…Although the effects of ginsenosides on amyloid beta (Aβ) aggregation in the brain are known, the role of ginsenoside F1 remains unclear. …”
Get full text
Article -
218
Triptolide Inhibited Cytotoxicity of Differentiated PC12 Cells Induced by Amyloid-Beta₂₅₋₃₅ via the Autophagy Pathway.
Published 2015-01-01“…Evidence shows that an abnormal deposition of amyloid beta-peptide25-35 (Aβ25-35) was the primary cause of the pathogenesis of Alzheimer's disease (AD). …”
Get full text
Article -
219
-
220
Strategy to discover full-length amyloid-beta peptide ligands using high-efficiency microarray technology
Published 2017-11-01Get full text
Article